• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[可待因-对乙酰氨基酚联合治疗与曲马多-对乙酰氨基酚治疗对中重度下腰痛控制效果的比较研究]

[Study of codeine-paracetamol combination treatment compared with tramadol-paracetamol in the control of moderate-to-severe low back pain].

作者信息

Colini Baldeschi G, Cobianchi M R

机构信息

UOSD Terapia Antalgica, Azienda Ospedaliera S. Giovanni Addolorata, Roma, Italia.

出版信息

Minerva Med. 2012 Jun;103(3):177-82.

PMID:22653097
Abstract

AIM

The objective of this study was to compare the analgesic efficacy and tolerability of tramadol hydrochloride compared with codeine phosphate in combination with paracetamol in patients with moderate-to-severe low back pain caused by osteoarthritis. In fact, while paracetamol is the analgesic of choice for this disease, in cases where this treatment may be ineffective, the therapeutic choice involves the addition of weak opioids. Due to the chronic nature of the disease, these drugs represent a safer alternative compared to anti-inflammatory drugs (NSAIDs) and selective inhibitors of cyclooxygenase 2 (COX-2).

METHODS

In the present study two combination treatments were considered: codeine-paracetamol (respectively 30 mg and 500 mg) and tramadol-paracetamol (respectively 37.5 mg and 325 mg). The study duration was 4 weeks and involved 38 patients (mean age 64.7 years). The effectiveness of the two treatments was assessed in terms of analgesic efficacy, tolerability and safety.

RESULTS

The results recorded after a week of treatment and at the end of the study showed a difference in favour of codeine-paracetamol association which showed slightly higher values ​​in pain improvement and, above all, was better tolerated in terms of adverse events and drop out.

CONCLUSION

The study, although conducted on a limited number of patients and for a relatively short time, demonstrates the greater efficacy and tolerability of the association codeine-paracetamol compared to tramadol-paracetamol.

摘要

目的

本研究的目的是比较盐酸曲马多与磷酸可待因联合对乙酰氨基酚在骨关节炎所致中重度腰痛患者中的镇痛效果和耐受性。事实上,虽然对乙酰氨基酚是该疾病的首选镇痛药,但在该治疗可能无效的情况下,治疗选择包括添加弱阿片类药物。由于该疾病的慢性性质,与抗炎药(非甾体抗炎药)和环氧化酶2(COX-2)选择性抑制剂相比,这些药物是更安全的选择。

方法

在本研究中,考虑了两种联合治疗:可待因 - 对乙酰氨基酚(分别为30毫克和500毫克)和曲马多 - 对乙酰氨基酚(分别为37.5毫克和325毫克)。研究持续时间为4周,涉及38名患者(平均年龄64.7岁)。从镇痛效果、耐受性和安全性方面评估了两种治疗的有效性。

结果

治疗一周后和研究结束时记录的结果显示,可待因 - 对乙酰氨基酚联合治疗更具优势,在疼痛改善方面显示出略高的值,最重要的是,在不良事件和退出方面耐受性更好。

结论

该研究虽然在有限数量的患者中进行且时间相对较短,但证明了可待因 - 对乙酰氨基酚联合治疗比曲马多 - 对乙酰氨基酚联合治疗具有更高的疗效和耐受性。

相似文献

1
[Study of codeine-paracetamol combination treatment compared with tramadol-paracetamol in the control of moderate-to-severe low back pain].[可待因-对乙酰氨基酚联合治疗与曲马多-对乙酰氨基酚治疗对中重度下腰痛控制效果的比较研究]
Minerva Med. 2012 Jun;103(3):177-82.
2
Combination analgesia in 2005 - a rational approach: focus on paracetamol-tramadol.2005年的联合镇痛——一种合理的方法:聚焦对乙酰氨基酚-曲马多
Clin Rheumatol. 2006;25 Suppl 1:S16-21. doi: 10.1007/s10067-006-0202-9. Epub 2006 Jun 2.
3
Comparison of the efficacy and tolerability of a paracetamol/codeine fixed-dose combination with tramadol in patients with refractory chronic back pain.对乙酰氨基酚/可待因固定剂量复方制剂与曲马多治疗难治性慢性背痛患者的疗效及耐受性比较
Arzneimittelforschung. 1998 Jun;48(6):675-9.
4
Weak opiate analgesics: modest practical merits.弱阿片类镇痛药:适度的实际效用。
Prescrire Int. 2004 Feb;13(69):22-5.
5
Codeine/acetaminophen and hydrocodone/acetaminophen combination tablets for the management of chronic cancer pain in adults: a 23-day, prospective, double-blind, randomized, parallel-group study.可待因/对乙酰氨基酚和氢可酮/对乙酰氨基酚复方片剂用于成人慢性癌痛的管理:一项为期23天的前瞻性、双盲、随机、平行组研究。
Clin Ther. 2007 Apr;29(4):581-7. doi: 10.1016/j.clinthera.2007.04.004.
6
Paracetamol/Tramadol association: the easy solution for mild-moderate pain.对乙酰氨基酚/曲马多联合用药:缓解轻至中度疼痛的简易方案。
Minerva Med. 2008 Aug;99(4):369-90.
7
Efficacy and tolerability of paracetamol/tramadol (325 mg/37.5 mg) combination treatment compared with tramadol (50 mg) monotherapy in patients with subacute low back pain: a multicenter, randomized, double-blind, parallel-group, 10-day treatment study.对乙酰氨基酚/曲马多(325毫克/37.5毫克)联合治疗与曲马多(50毫克)单药治疗亚急性下腰痛患者的疗效和耐受性:一项多中心、随机、双盲、平行组、为期10天的治疗研究。
Clin Ther. 2006 Oct;28(10):1592-606. doi: 10.1016/j.clinthera.2006.10.001.
8
Paracetamol + tramadol: new preparation. No advance.对乙酰氨基酚+曲马多:新制剂。无进展。
Prescrire Int. 2003 Dec;12(68):211-3.
9
[Economic evaluation of tramadol/paracetamol in the management of pain in patients with osteoarthritis in Spain].[曲马多/对乙酰氨基酚用于西班牙骨关节炎患者疼痛管理的经济学评估]
Reumatol Clin. 2011 Jul-Aug;7(4):241-7. doi: 10.1016/j.reuma.2010.11.016. Epub 2011 Mar 23.
10
A single blind controlled comparison of tramadol/paracetamol combination and paracetamol in hand and foot surgery. A prospective study.曲马多/对乙酰氨基酚复方制剂与对乙酰氨基酚在手和足外科手术中的单盲对照比较。一项前瞻性研究。
In Vivo. 2011 Mar-Apr;25(2):291-5.

引用本文的文献

1
Advanced Carbon-Based Polymeric Nanocomposites for Forensic Analysis.用于法医分析的先进碳基聚合物纳米复合材料。
Polymers (Basel). 2022 Aug 31;14(17):3598. doi: 10.3390/polym14173598.
2
Graphene-Based Electrochemical Sensors for Psychoactive Drugs.用于精神活性药物的基于石墨烯的电化学传感器。
Nanomaterials (Basel). 2022 Jun 30;12(13):2250. doi: 10.3390/nano12132250.